About the Authors
- Martin Köbel
-
Affiliations Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada , Institute of Pathology, Charité Hospital, Berlin, Germany
- Steve E Kalloger
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Niki Boyd
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Steven McKinney
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Erika Mehl
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Chana Palmer
-
Affiliation Canary Foundation, San Jose, California, United States of America
- Samuel Leung
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Nathan J Bowen
-
Affiliation School of Biology, Georgia Institute of Technology, and Ovarian Cancer Institute, Atlanta, Georgia, United States of America
- Diana N Ionescu
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Ashish Rajput
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Leah M Prentice
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Dianne Miller
-
Affiliation Department of Gynecology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Jennifer Santos
-
Affiliation Cheryl Brown Ovarian Cancer Outcomes Unit, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- Kenneth Swenerton
-
Affiliation Cheryl Brown Ovarian Cancer Outcomes Unit, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- C. Blake Gilks
-
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
- David Huntsman
-
*To whom correspondence should be addressed. E-mail: dhuntsma@bccancer.bc.ca
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
DH conceived the study. MK, CBG, and DH designed the study. MK, SEK, NB, SM, EM, CP, SL, NJB, DNI, AR, LMP, DM, JS, KS, and DH were involved in acquisition of data and analysis/interpretation of the data. MK had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of data analysis. SL created companion website. MK and CBG wrote the first draft of the manuscript. MK, SEK, CP, LMP, and DH participated in revising the manuscript. MK, SEK, NB, SM, EM, CP, SL, NJB, DNI, AR, LMP, DM, JS, KS, CBG, and DH approved submission of the final draft.